Baxter Warning Letter Highlights Beta-La
Baxter International Inc, was issued an FDA Warning Letter following cGMP violations observed during an
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
